NSV Partners III LP, 10% Owner at Ventyx Biosciences, Inc. (VTYX), sold 199,207 shares at $37.51 ($7.7M) on 2023-04-21, disclosed to the SEC on 2023-04-25.
Open-market sale of $7.7M VTYX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.51 | 8,642 | $324K | 4.2% |
| 2 | $37.51 | 8,642 | $324K | 4.2% |
| 3 | $37.95 | 25,139 | $954K | 12.4% |
| 4 | $37.95 | 25,139 | $954K | 12.4% |
| 5 | $38.90 | 65,426 | $2.5M | 33.2% |
| 6 | $38.90 | 65,426 |
| $2.5M |
| 33.2% |
| 7 | $38.88 | 793 | $31K | 0.4% |
| Total | $38.54 avg | 199,207 | $7.7M | 100% |
| Filing → |
| VTYX | SELL | 2023-07-19 | $7.0M | — | Filing → |
| VTYX | SELL | 2023-07-06 | $10.5M | — | Filing → |
| VTYX | SELL | 2023-06-16 | $1.8M | — | Filing → |